C. Labbé-Devilliers

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

Thomas Bachelot, Gilles Romieu, Mario Campone et al. · The Lancet Oncology · 2012 · 742 citations

Medicine, Oncology, Pharmacology +16

Validation of Dynamic Contrast-Enhanced Ultrasound in Predicting Outcomes of Antiangiogenic Therapy for Solid Tumors

Nathalie Lassau, Julia Bonastre, Michèle Kind et al. · Investigative Radiology · 2014 · 130 citations · Full text

Medicine, Oncology, Radiology +17

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin

Jean‐Baptiste Delhorme, François Séverac, Gerlinde Avérous et al. · British journal of surgery · 2018 · 52 citations

Medicine, Oncology, Surgery +8

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial

Jean‐Yves Pierga, François‐Clément Bidard, Claire Cropet et al. · Annals of Oncology · 2013 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +17

Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab

Nathalie Lassau, B Coiffier, Michèle Kind et al. · Annals of Oncology · 2016 · 33 citations · Full text

Medicine, Oncology, Radiology +14